Helmet continuous positive airway pressure as noninvasive ventilation for COVID-19 patients; a systematic review and meta-analysis of randomized trials
Postgraduate Medical Journal · 2025
DOI: 10.1093/postmj/qgaf038 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Postgraduate Medical Journal, 2025. Verfasst von Yongke Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, 310006, Hangzho…. Hauptthemen laut MEDLINE: COVID-19, Continuous Positive Airway Pressure, Noninvasive Ventilation, Respiratory Insufficiency. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Medical and Health Technology Major Project of Hangzhou.
Abstract (Originalsprache)
Background
The COVID-19 pandemic has challenged healthcare systems globally, highlighting the need for effective respiratory support strategies. Helmet continuous positive airway pressure (CPAP) has emerged as a potential noninvasive ventilation (NIV) method for COVID-19 patients.
Methods
We searched PubMed, EMBASE, the Cochrane Library, and Scopus from December 1, 2019, to June 1, 2024. Randomized controlled trials (RCTs) comparing helmet CPAP therapy with standard oxygen therapy or other forms of NIV in COVID-19 patients with acute hypoxemic respiratory failure were included. Random effects meta-analyses were performed to calculate pooled risk ratios (RRs) with 95% confidence intervals (95% CIs).
Results
Three RCTs involving 580 patients were included in this analysis. There was no significant differences (P > 0.05) in mortality at 28 d (RR, 1.20; 95% CI, 0.84–1.71), 60–90 d (1.02, 95% CI, 0.75–1.37), or 180 d (0.98, 95% CI, 0.76–1.25) between the helmet CPAP group and the control group as well as similar intubation rates (RR 0.90; 95% CI, 0.73–1.10) and times to intubation. However, helmet CPAP was associated with significantly shorter ICU stays and hospital stays. The adverse event rates were similar between the groups. Patient comfort, as measured by the EQ-VAS, was significantly better with the CPAP helmet.
Conclusion
The use of helmet CPAP for the treatment of respiratory failure in patients with COVID-19 showed comparable intubation rates and shorter ICU and hospital stays without increasing mortality or adverse events. Key messages What is already known about this topic? Noninvasive ventilation (NIV) methods, such as helmet CPAP, treat patients with acute hypoxemic respiratory failure. The effectiveness of helmet CPAP for COVID-19 patients is unknown. What this study adds? This study shows that helmet CPAP has similar intubation and mortality rates to standard treatments in COVID-19 acute respiratory failure patients. It also highlights how helmet CPAP reduces ICU and hospital stays and improves patient comfort. How this study might affect research, practice, or policy? The findings of this study could lead to future research into helmet CPAP approaches for COVID-19 and other respiratory failure patients. They could also influence clinical practice and healthcare policy by emphasizing helmet CPAP as a preferable noninvasive ventilation technique for similar patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, 310006, Hangzhou, China.
- Department of Intensive Care Unit, Hangzhou Geriatric Hospital, 50 Jingshen Road, 310022, Hangzhou, China.
- Department of Intensive Care Unit, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 261 Huansha Road, 310006, Hangzhou, China.
- Department of Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, No. N1, Shangcheng Avenue, 320000, Yiwu, Zhej…
ORCID-Profile: Hayat Khizar
Förderung
- Medical and Health Technology Major Project of Hangzhou
Zitieren
APA
Zheng, Y., Zhou, S., Gu, N., Zeng, X., Khizar, H., & Zeng, L. (2025). Helmet continuous positive airway pressure as noninvasive ventilation for COVID-19 patients; a systematic review and meta-analysis of randomized trials. Postgraduate Medical Journal. https://doi.org/10.1093/postmj/qgaf038
Vancouver
Zheng Y, Zhou S, Gu N, Zeng X, Khizar H, Zeng L. Helmet continuous positive airway pressure as noninvasive ventilation for COVID-19 patients; a systematic review and meta-analysis of randomized trials. Postgraduate Medical Journal. 2025. doi:10.1093/postmj/qgaf038
BibTeX
@article{Zheng2025,
author = {Zheng, Yongke and Zhou, Shihan and Gu, Nanyuan and Zeng, Xiaokang and Khizar, Hayat and Zeng, Longhuan},
title = {Helmet continuous positive airway pressure as noninvasive ventilation for COVID-19 patients; a systematic review and meta-analysis of randomized trials},
journal = {Postgraduate Medical Journal},
year = {2025},
doi = {10.1093/postmj/qgaf038}
}
EUVIMED